GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Series GSE72252
Query DataSets for GSE72252
Status
Public on Apr 08, 2016
Title
DNaseI hypersensitivity assay and ER, GR, and FoxA1 binding patterns in breast cancer cells
Organism
Homo sapiens
Experiment type
Genome binding/occupancy profiling by high throughput sequencing
Summary
This SuperSeries is composed of the SubSeries listed below.
Overall design
Refer to individual Series
Citation(s)
27062924
,
34403459
Submission date
Aug 20, 2015
Last update date
Oct 06, 2021
Contact name
Songjoon Baek
Organization name
NCI / NIH
Department
CCR
Lab
LRBGE
Street address
41 Library Drive
City
Bethesda
State/province
MD
ZIP/Postal code
20892
Country
USA
Platforms (2)
GPL11154
Illumina HiSeq 2000 (Homo sapiens)
GPL18573
Illumina NextSeq 500 (Homo sapiens)
Samples (57)
Less...
More...
GSM1858616
untreated rep#1 GR ChIP-seq GH913
GSM1858617
untreated rep#2 GR ChIP-seq GH921
GSM1858618
Dex rep#1 GR ChIP-seq GH1158
GSM1858619
Dex rep#2 GR ChIP-seq GH1159
GSM1858620
untreated rep#1 ER ChIP-seq GH620
GSM1858621
untreated rep#2 ER ChIP-seq GH628
GSM1858622
E2 rep#1 ER ChIP-seq GH622
GSM1858623
E2 rep#2 ER ChIP-seq GH630
GSM1858624
untreated rep#1 FoxA1 ChIP-seq GH917
GSM1858625
untreated rep#2 FoxA1 ChIP-seq GH925
GSM1858626
Dex rep#1 FoxA1 ChIP-seq GH918
GSM1858627
Dex rep#2 FoxA1 ChIP-seq GH926
GSM1858628
E2 rep#1 FoxA1 ChIP-seq GH919
GSM1858629
E2 rep#2 FoxA1 ChIP-seq GH927
GSM1858630
INPUT ChIP-seq GH929
GSM1858631
untreated rep#1 GR ChIP-seq GH995
GSM1858632
untreated rep#2 GR ChIP-seq GH1004
GSM1858633
Dex rep#1 GR ChIP-seq GH996
GSM1858634
Dex rep#2 GR ChIP-seq GH1005
GSM1858635
untreated rep#1 ER ChIP-seq GH999
GSM1858636
untreated rep#2 ER ChIP-seq GH1008
GSM1858637
E2 rep#1 ER ChIP-seq GH1001
GSM1858638
E2 rep#2 ER ChIP-seq GH1010
GSM1858639
untreated rep#1 FoxA1 ChIP-seq GH1062
GSM1858640
untreated rep#2 FoxA1 ChIP-seq GH1066
GSM1858641
Dex rep#1 FoxA1 ChIP-seq GH1063
GSM1858642
Dex rep#2 FoxA1 ChIP-seq GH1067
GSM1858643
E2 rep#1 FoxA1 ChIP-seq GH1064
GSM1858644
E2 rep#2 FoxA1 ChIP-seq GH1068
GSM1858645
INPUT ChIP-seq GH1003
GSM1858646
untreated rep#1 GR ChIP-seq GH943
GSM1858647
untreated rep#2 GR ChIP-seq GH987
GSM1858648
Dex rep#1 GR ChIP-seq GH944
GSM1858649
Dex rep#2 GR ChIP-seq GH988
GSM1858650
untreated rep#1 ER ChIP-seq GH983
GSM1858651
untreated rep#2 ER ChIP-seq GH991
GSM1858652
E2 rep#1 ER ChIP-seq GH985
GSM1858653
E2 rep#2 ER ChIP-seq GH993
GSM1858654
untreated rep#1 FoxA1 ChIP-seq GH1070
GSM1858655
untreated rep#2 FoxA1 ChIP-seq GH1460
GSM1858656
Dex rep#1 FoxA1 ChIP-seq GH1071
GSM1858657
Dex rep#2 FoxA1 ChIP-seq GH1461
GSM1858658
E2 rep#1 FoxA1 ChIP-seq GH1072
GSM1858659
E2 rep#2 FoxA1 ChIP-seq GH1462
GSM1858660
INPUT ChIP-seq GH947
GSM1858661
untreated rep#1 DNase-seq GH1501
GSM1858662
untreated rep#2 DNase-seq GH1571
GSM1858663
Dex rep#1 DNase-seq GH1502
GSM1858664
Dex rep#2 DNase-seq GH1572
GSM1858665
E2 rep#1 DNase-seq GH1503
GSM1858666
E2 rep#2 DNase-seq GH1573
GSM1858667
untreated rep#1 DNase-seq GH1563
GSM1858668
untreated rep#2 DNase-seq GH1567
GSM1858669
Dex rep#1 DNase-seq GH1564
GSM1858670
Dex rep#2 DNase-seq GH1568
GSM1858671
E2 rep#1 DNase-seq GH1565
GSM1858672
E2 rep#2 DNase-seq GH1569
This SuperSeries is composed of the following SubSeries:
GSE72249
Characterization of ER, GR, and FoxA1 binding patterns in breast cancer cells treated with either Dex or E2
GSE72250
Characterization of chromatin accessibility through the DNaseI hypersensitivity assay in breast cancer cells treated with either Dex or E2
Relations
BioProject
PRJNA293468
Download family
Format
SOFT formatted family file(s)
SOFT
MINiML formatted family file(s)
MINiML
Series Matrix File(s)
TXT
Supplementary file
Size
Download
File type/resource
GSE72252_RAW.tar
5.3 Gb
(http)
(custom)
TAR (of BEDGRAPH)
SRA Run Selector
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|